Invitae kicks off 2015 medtech IPOs with $86m filing
This article was originally published in Clinica
Executive Summary
After a bumper crop of medtech initial public offerings last year, the pace shows no sign of slowing. Latest to try its luck is genetic data management specialist Invitae, which has filed for a $86m IPO. The San Francisco, California company did not give any pricing details, but plans to trade on the New York Stock Exchange under the ticker symbol NVTA.